| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0074-0039-56 | 0074-0039 | HUMAN PRESCRIPTION DRUG | Orilissa | Elagolix | TABLET, FILM COATED | ORAL | 20180723 | N/A | NDA | NDA210450 | AbbVie Inc. | ELAGOLIX SODIUM | 200 mg/1 | 4 BLISTER PACK in 1 CARTON (0074-0039-56) / 14 TABLET, FILM COATED in 1 BLISTER PACK |
| 0074-0039-14 | 0074-0039 | HUMAN PRESCRIPTION DRUG | Orilissa | Elagolix | TABLET, FILM COATED | ORAL | 20180723 | N/A | NDA | NDA210450 | AbbVie Inc. | ELAGOLIX SODIUM | 200 mg/1 | 1 BLISTER PACK in 1 CARTON (0074-0039-14) / 14 TABLET, FILM COATED in 1 BLISTER PACK |
| 0074-0038-28 | 0074-0038 | HUMAN PRESCRIPTION DRUG | Orilissa | Elagolix | TABLET, FILM COATED | ORAL | 20180723 | N/A | NDA | NDA210450 | AbbVie Inc. | ELAGOLIX SODIUM | 150 mg/1 | 4 BLISTER PACK in 1 CARTON (0074-0038-28) / 7 TABLET, FILM COATED in 1 BLISTER PACK |
| 0074-0038-07 | 0074-0038 | HUMAN PRESCRIPTION DRUG | Orilissa | Elagolix | TABLET, FILM COATED | ORAL | 20180723 | N/A | NDA | NDA210450 | AbbVie Inc. | ELAGOLIX SODIUM | 150 mg/1 | 1 BLISTER PACK in 1 CARTON (0074-0038-07) / 7 TABLET, FILM COATED in 1 BLISTER PACK |